|
|
Volumn 117, Issue 3, 2009, Pages 569-570
|
|
Do GnRH analogs protect against ovarian toxicity of chemotherapy?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYCLOPHOSPHAMIDE;
FLUOROURACIL;
FOLLITROPIN;
GOSERELIN;
METHOTREXATE;
TAMOXIFEN;
ADD ON THERAPY;
ADJUVANT THERAPY;
ARTICLE;
CANCER ADJUVANT THERAPY;
CANCER HORMONE THERAPY;
CANCER PATIENT;
CHEMOSENSITIVITY;
CLINICAL TRIAL;
DRUG EFFECT;
ESTROGEN SYNTHESIS;
FOLLOW UP;
HUMAN;
MENSTRUATION;
MOLECULAR MECHANICS;
OVARY CYCLE;
OVARY FOLLICLE MATURATION;
OVARY FUNCTION;
OVARY INSUFFICIENCY;
OVULATION INDUCTION;
PREMENOPAUSE;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
ANTINEOPLASTIC AGENTS;
BREAST NEOPLASMS;
FEMALE;
GONADOTROPIN-RELEASING HORMONE;
HUMANS;
OVARIAN FAILURE, PREMATURE;
OVARY;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
|
|
EID: 70349562954
PISSN: 01676806
EISSN: 15737217
Source Type: Journal
DOI: 10.1007/s10549-009-0338-9 Document Type: Article |
|
Times cited : (2)
|
|
References (5)
|
